ZA943201B - Novel lupane derivatives their preparation and pharmceutical compositions contiaining them - Google Patents

Novel lupane derivatives their preparation and pharmceutical compositions contiaining them

Info

Publication number
ZA943201B
ZA943201B ZA943201A ZA943201A ZA943201B ZA 943201 B ZA943201 B ZA 943201B ZA 943201 A ZA943201 A ZA 943201A ZA 943201 A ZA943201 A ZA 943201A ZA 943201 B ZA943201 B ZA 943201B
Authority
ZA
South Africa
Prior art keywords
contiaining
preparation
novel
lupane derivatives
pharmceutical compositions
Prior art date
Application number
ZA943201A
Inventor
Norbert Dereu
Michel Evers
Christele Poujade
Francoise Soler
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA943201B publication Critical patent/ZA943201B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/50—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/90—Ring systems containing bridged rings containing more than four rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA943201A 1993-05-11 1994-05-09 Novel lupane derivatives their preparation and pharmceutical compositions contiaining them ZA943201B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9305619A FR2705094B1 (en) 1993-05-11 1993-05-11 New lupane derivatives, their preparation and the pharmaceutical compositions containing them.

Publications (1)

Publication Number Publication Date
ZA943201B true ZA943201B (en) 1995-01-16

Family

ID=9446985

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA943201A ZA943201B (en) 1993-05-11 1994-05-09 Novel lupane derivatives their preparation and pharmceutical compositions contiaining them

Country Status (7)

Country Link
EP (1) EP0698008A1 (en)
JP (1) JPH08509968A (en)
AU (1) AU6787994A (en)
CA (1) CA2162702A1 (en)
FR (1) FR2705094B1 (en)
WO (1) WO1994026695A1 (en)
ZA (1) ZA943201B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750578A (en) * 1997-02-11 1998-05-12 Regents Of The University Of Minnesota Use of betulin and analogs thereof to treat herpesvirus infection
US6048847A (en) * 1997-09-30 2000-04-11 Dabur Research Foundation Use of betulinic acid and its derivatives for inhibiting cancer growth and a method of monitoring this
US6228850B1 (en) 1997-09-30 2001-05-08 Dabur Research Foundation Antiangiogenic activity of betulinic acid and its derivatives
US6670345B1 (en) 1997-09-30 2003-12-30 Dabur Research Foundation Betulinic acid derivatives for inhabiting cancer growth and process for the manufacture of betulinic acid
DE69832363D1 (en) * 1998-03-18 2005-12-22 Dabur Pharma Ltd Betulinic derivatives for inhibiting cancer growth
US6214814B1 (en) 1998-03-18 2001-04-10 Dabur Research Foundation Use of betulinic acid derivatives for inhibiting cancer growth
US6482857B1 (en) 1998-07-17 2002-11-19 The University Of Texas Southwestern Medical Center Compositions which contain triterpenes for regulating hair growth
US6124362A (en) 1998-07-17 2000-09-26 The Procter & Gamble Company Method for regulating hair growth
US6369101B1 (en) 1999-02-26 2002-04-09 Regents Of The University Of Minnesota Therapeutic method to treat herpes virus infection
JP2005194192A (en) * 2002-01-11 2005-07-21 Meiji Seika Kaisha Ltd (4-OXOPIPERIDIN-1-YL)BENZOIC ACID DERIVATIVE AND METHOD FOR PRODUCING INTEGRIN alphavbeta3 INHIBITOR USING THE SAME

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01143832A (en) * 1987-12-01 1989-06-06 Toa Nenryo Kogyo Kk Carcinostatic agent

Also Published As

Publication number Publication date
FR2705094A1 (en) 1994-11-18
JPH08509968A (en) 1996-10-22
WO1994026695A1 (en) 1994-11-24
FR2705094B1 (en) 1995-08-04
EP0698008A1 (en) 1996-02-28
AU6787994A (en) 1994-12-12
CA2162702A1 (en) 1994-11-24

Similar Documents

Publication Publication Date Title
IL103731A0 (en) Lupane derivatives,their preparation and pharmceutical compositions which contain them
GB2296725B (en) Cellulose compositions and their preparation
GB2294465A8 (en) Perfluoroelastomeric compositions and methods
NZ233320A (en) 3-substituted-2-oxo-indole derivatives and pharmaceutical compositions
IL111221A0 (en) N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them
GB9302049D0 (en) Compositions of new matter
EP0707480A4 (en) Antineoplastic compositions and methods of use
NZ235270A (en) Diazepinone derivatives and pharmaceutical compositions
EP0502080A4 (en) Anti-inflammatory compositions and methods
NZ233790A (en) Benzocycloalkane derivatives and pharmaceutical compositions
NZ233011A (en) Thieno-triazole-diazepine and pharmaceutical compositions
EP0429585A4 (en) Cytochalasin compositions and therapeutic methods
ZA943201B (en) Novel lupane derivatives their preparation and pharmceutical compositions contiaining them
IL116015A0 (en) Iminooxymethyleneanilides thdir preparation and compositions containing them
IL116190A0 (en) Eleutherobin and analogs thereof
ZA945597B (en) Methyiguanidine derivatives process for their preparation and the compositions containing them
NZ234174A (en) Dihydroindenoindole derivatives and compositions containing them
ZA948689B (en) New taxicin derivatives their preparation and pharmaceutical compositions containing them
ZA943202B (en) Novell lupane derivatives their preparation and pharmaceutical compositions which contain them
NZ235779A (en) 13-epi-avermectin derivatives and anti-parasitic compositions thereof
GB9226536D0 (en) Foodstuffs and other compositions
NZ233013A (en) Substituted thieno-triazolo-diazepine derivatives and pharmaceutical compositions
IL121691A0 (en) N-benzylazolium derivatives their preparation and compositions containing them
AU5847694A (en) Chlorofluoroether compositions and preparation thereof
GR3036556T3 (en) Compositions having antiviral properties and preparation process